ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications - Paclitaxel & Cisplatin +/- Atezo & Tiragolumab as 1L Treatment for Advanced Esophageal Carcinoma"

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications - Paclitaxel & Cisplatin +/- Atezo & Tiragolumab as 1L Treatment for Advanced Esophageal Carcinoma"

By Insights from 2024 ASCO® GI Annual Meeting FEATURING Yelena Janjigian, Samuel Cytryn, Samuel Klempner

0 views

February 7, 2024

Check out other trials discussed by the panelists:
1) CheckMate-8HW
2) MATTERHORN & KEYNOTE-585
3) ctDNA in Colon Cancer

Comments 0

Explore the mechanism of Action of a TKI in HCC

Feat. W. Keiser

Safety and Efficacy Data of a TKI Monotherapy in HCC

Feat. J. Mizrahi

ASCO® 2024 Summary: "Expert Panel Discussion on Upper-GI Cancer…

Feat. N. Uboha, A. Turk, K. Spencer, M. Cecchini

27:12

Moffitt Cancer Center

Year in Review: Upper GI Cancers

Feat. R. Kim, R. Mehta

07:27

Jason Levy

Opus One: Final Results - RFA in Axial Skeleton

17:23

Insights from 2024 ASCO® GI Annual Meeting

ASCO® GI 2024 Summary: "Esophageal Squamous Cell Carcinoma Key …

Feat. R. Kim, R. Mehta

23:26

Yale Cancer Center

GI Cancer Updates: The Role of Surgery After Neoadjuvant Systemic Th…

Feat. C. Balch

09:58

Elizabeth Smyth

Controversies in the Predictive Value of PD-L1 for Anti-PD-1 Benefit…

Feat. R. Sundar

18:51

Hope for Stomach Cancer

1L Therapy for Stage 4 Gastroesophageal Cancers: The Role of Biomark…

Feat. D. Catenacci

15:24

Horizon CME

MRD in GI Malignancies: Current Clinical Utility of ctDNA

Feat. A. Scott

06:39

Oncology Data Advisor

Additional Advances in Esophagogastric Cancer Research and Clinical …

Feat. J. Ajani

04:01

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "3Yr Follow-Up of RATIONALE-306 - Tisleliz…

Feat. H. Yoon

41:38

Dana-Farber Cancer Institute

Let Me Eat: The Road to Reconstructing the Esophagus

Feat. J. Wee

15:47

Integrity CE

Resectable GEJ Adenocarcinoma: Case Presentation and Expert Panel Di…

Feat. K. Bever, R. Voong, J. Hernandez, S. Klempner

18:55

ImmunoTherapy Bridge 2023

Immunotherapy in GI Cancer: Current Treatment Landscape and Challeng…

Feat. A. Avallone

11:02

ASCO GI 2023 Conference Coverage

ASCO GI 2023 3-Year Follow-Up From CheckMate 649: Nivo + Chemo vs. C…

Feat. Y. Y. Janjigian

23:56

Scripps Health

Targeted Therapy Approaches for Upper GI Cancer

Feat. M. Strickland

11:57

COR2ED The Heart of Medical Education

ASCO® 2024 Summary: "Latest Practice-Changing Data in Breast Ca…

Feat. M. Socinski, P. R. Galle, S. Dawood, E. Smyth, S. Klempner

57:57

Hope for Stomach Cancer

1L Therapy for HER2+ Stage 4 Gastroesophageal Cancers

Feat. D. Catenacci

19:29

Total Health

Case-Based Clinical Updates in GI Cancer: 56 y/o Male With GEJ Adeno…

Feat. R. Mehta, M. Tejani, K. Blue

44:18

Debbie's Dream Foundation

ASCO® 2023 Insights: "What's New in Stomach and Esophageal…

Feat. S. Klempner

23:39

OncoAlert

Year in Review: Gastric, Esophageal, & Liver Cancers

Feat. S. Gill

Login

Login

Join VuMedi

ASCO® GI 2024 Panel Discussion: "SKYSCRAPER-08 Clinical Implications - Paclitaxel & Cisplatin +/- Atezo & Tiragolumab as 1L Treatment for Advanced Esophageal Carcinoma"

Recommended